Skip to main content
logo
KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
14.66
+1.14 (8.43%)
At close: Dec 3, 2025, 4:00 PM EST
14.67
+0.01 (0.07%)
After-hours: Dec 3, 2025, 5:20 PM EST

KalVista Pharmaceuticals Revenue

KalVista Pharmaceuticals had revenue of $13.69M in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $1.43M.

Revenue (ttm)
$1.43M
Revenue Growth
n/a
P/S Ratio
516.45
Revenue / Employee
$5,281
Employees
270
Market Cap
741.01M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Apr 30, 2025---
Apr 30, 2024---
Apr 30, 2023---
Apr 30, 2022---
Apr 30, 2021---
Apr 30, 2020 Pro Pro Pro
Apr 30, 2019 Pro Pro Pro
Apr 30, 2018 Pro Pro Pro
Apr 30, 2017 Pro Pro Pro
Apr 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

KALV News

More News